Pharmaceutical composition for preventing vitreous opacity
A technology of vitreous opacity and composition, which is applied in the direction of drug combinations, active ingredients of heterocyclic compounds, and pharmaceutical formulations, and can solve problems such as slow metabolism, complicated etiology and pathogenesis, and difficult to cure
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0038] Embodiment 1: the pharmaceutical composition and preparation method thereof of preventing and treating vitreous opacity
[0039] The composition and parts by weight of the raw materials of the pharmaceutical composition for preventing and treating vitreous opacity are: 4850g of syringa, 65g of katydid, 3600g of asterite, 60g of cucurbitacin L, 105g of Agrimony lactone, and 65g of sophorin;
[0040] Preparation:
[0041] (1) According to the ratio of raw materials, take katydid, asterite, yizhuxiang, cucurbitacin L, agrilactone, and sophorin, mix them evenly, use ethanol with a concentration of 49% by weight as a solvent, and warm at 30.5°C Dipping extraction, the number of times of extraction is 25 times, each extraction time is 17 hours, and the amount of solvent is 44 times of the total weight of the crude drug each time, filtering to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to The relative density is 1.04, filtered, the drug...
Embodiment 2
[0044] Embodiment 2: the pharmaceutical composition of preventing and treating vitreous opacity and preparation method thereof
[0045] The composition and parts by weight of the raw materials of the pharmaceutical composition for preventing and treating vitreous opacity are: 4800g of syringa, 3500g of katydid 80g, 3500g of cucurbitacin L70g, 100g of agrimones, and 70g of sophorin;
[0046] Preparation:
[0047] (1) According to the ratio of raw materials, take katydid, asterite, yizhuxiang, cucurbitacin L, agrilactone, and sophorin, mix them evenly, use ethanol with a concentration of 49% by weight as a solvent, and warm at 30.5°C Dipping extraction, the number of times of extraction is 25 times, each extraction time is 17 hours, and the amount of solvent is 44 times of the total weight of the crude drug each time, filtering to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to The relative density is 1.04, filtered, the drug solution passe...
Embodiment 3
[0050] Embodiment 3: the pharmaceutical composition and preparation method thereof of preventing and treating vitreous opacity
[0051] The composition and parts by weight of the raw materials of the medicinal composition for preventing and treating vitreous opacity are: 4900g of syringa, 50g of katydid, 3700g of asterite, 40g of cucurbitacin L, 110g of Agrimony lactone, and 60g of sophorin;
[0052] Preparation:
[0053] (1) According to the ratio of raw materials, take katydid, asterite, yizhuxiang, cucurbitacin L, agrilactone, and sophorin, mix them evenly, use ethanol with a concentration of 49% by weight as a solvent, and warm at 30.5°C Dipping extraction, the number of times of extraction is 25 times, each extraction time is 17 hours, and the amount of solvent is 44 times of the total weight of the crude drug each time, filtering to obtain medicinal residue A and extract A, extract A reclaims ethanol, concentrates to The relative density is 1.04, filtered, the drug solu...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com